Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001206774-05-000364
Filing Date
2005-03-16
Accepted
2005-03-16 15:38:32
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 bp7143110k.htm 10-K 657191
2 bp71431ex23.htm EX-23 1909
3 bp71431ex311.htm EX-31.1 14124
4 bp71431ex312.htm EX-31.2 13756
5 bp71431ex321.htm EX-32.1 2979
6 bp71431ex322.htm EX-32.2 2985
  Complete submission text file 0001206774-05-000364.txt   694894
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 05685293
SIC: 2836 Biological Products, (No Diagnostic Substances)